Vasohibin-2 promotes proliferation and metastasis of cervical cancer cells by regulating epithelial-mesenchymal transition.
10.12122/j.issn.1673-4254.2022.07.02
- Author:
Jun WANG
1
;
Cai Xian YU
1
;
Xiao Xia JIANG
1
;
Xiao Liu WU
1
;
Yue JIA
1
;
Hong Ping ZHANG
1
;
Zheng LI
1
Author Information
1. Department of Gynecology, Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital), Kunming 650118, China.
- Publication Type:Journal Article
- Keywords:
cell proliferation;
cervical cancer;
epithelial-mesenchymal transition;
flotillin- 1;
tumor metastasis;
vasohibin- 2
- MeSH:
Angiogenic Proteins/metabolism*;
Cell Line, Tumor;
Cell Movement;
Cell Proliferation/genetics*;
Epithelial-Mesenchymal Transition/genetics*;
Female;
Gene Expression Regulation, Neoplastic;
Humans;
Lymphatic Metastasis;
RNA, Messenger;
Transforming Growth Factor beta/metabolism*;
Uterine Cervical Neoplasms/pathology*
- From:
Journal of Southern Medical University
2022;42(7):966-975
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the role of vasohibin-2 (VASH2) in regulation of proliferation and metastasis of cervical cancer cells.
METHODS:We analyzed the differentially expressed genes between cervical cancer cells with flotillin-1 overexpression and knockdown by RNA-seq combined with analysis of public databases. The expression levels of VASH2 were examined in normal cervical epithelial cells (HcerEpic), cervical cancer cell lines (HeLa, C-33A, Ca ski, SiHa and MS751) and fresh cervical cancer tissues with different lymph node metastasis status. We further tested the effects of lentivirus-mediated overexpression and interference of VASH2 on proliferation, migration, invasion and lymphatic vessel formation of the cervical cancer cells and detected the expression levels of key epithelial-mesenchymal transition (EMT) markers and TGF-β mRNA.
RESULTS:RNA-seq and analysis of public databases showed that VASH2 expression was significantly upregulated in cervical cancer cells exogenously overexpressing flotillin-1 (P < 0.05) and downregulated in cells with flotillin-1 knockdown (P < 0.05), and was significantly higher in cervical cancer tissues with lymph node metastasis than in those without lymph node metastasis (P < 0.01). In cervical cancer cell lines Ca Ski, SiHa, and MS751 and cervical cancer tissue specimens with lymph node metastasis, VASH2 expression was also significantly upregulated as compared with HcerEpic cells and cervical cancer tissues without lymph node metastasis (P < 0.05). Exogenous overexpression of VASH2 significantly promoted proliferation, migration, invasion and lymphatic vessel formation of cervical cancer cells, whereas these abilities were significantly inhibited in cells with VASH2 knockdown (P < 0.05). The cervical cancer cells overexpressing VASH2 showed significant down- regulation of e-cadherin and up- regulation of N-cadherin, Vimentin and VEGF-C, while the reverse changes were detected in cells with VASH2 knockdown (P < 0.05). TGF-β mRNA expression was significantly up-regulated in cervical cancer cells overexpressing VASH2 and down-regulated in cells with VASH2 knockdown (P < 0.001).
CONCLUSION:Flotillin-1 may participate in TGF-β signaling pathway-mediated EMT through its down-stream target gene VASH2 to promote the proliferation, migration, invasion and lymphatic vessel formation of cervical cancer cells in vitro.
